On the Complexity of Brain Disorders: A Symptom-Based Approach

Mounting evidence shows that brain disorders involve multiple and different neural dysfunctions, including regional brain damage, change to cell structure, chemical imbalance, and/or connectivity loss among different brain regions. Understanding the complexity of brain disorders can help us map these neural dysfunctions to different symptom clusters as well as understand subcategories of different brain disorders. Here, we discuss data on the mapping of symptom clusters to different neural dysfunctions using examples from brain disorders such as major depressive disorder (MDD), Parkinson’s disease (PD), schizophrenia, posttraumatic stress disorder (PTSD) and Alzheimer’s disease (AD). In addition, we discuss data on the similarities of symptoms in different disorders. Importantly, computational modeling work may be able to shed light on plausible links between various symptoms and neural damage in brain disorders.

[1]  S. Bestmann,et al.  Transcranial Magnetic Stimulation , 2016, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[2]  C. Yeager.  Trauma and Posttraumatic Stress Disorder , 2015 .

[3]  C. White,et al.  Drift diffusion model of reward and punishment learning in schizophrenia: Modeling and experimental data , 2015, Behavioural Brain Research.

[4]  Taiki Takahashi,et al.  Reinforcement learning in depression: A review of computational research , 2015, Neuroscience & Biobehavioral Reviews.

[5]  H. Lohmann,et al.  P12. Neural correlates of apraxia in mild dementia of Alzheimer’s disease – A voxel-based morphometry study , 2015, Clinical Neurophysiology.

[6]  Rick A Adams,et al.  Computational Psychiatry: towards a mathematically informed understanding of mental illness , 2015, Journal of Neurology, Neurosurgery & Psychiatry.

[7]  C. Myers,et al.  Increased generalization of learned associations is related to re-experiencing symptoms in veterans with symptoms of post-traumatic stress , 2015, Stress.

[8]  Hartwig R. Siebner,et al.  Abnormal dopaminergic modulation of striato-cortical networks underlies levodopa-induced dyskinesias in humans , 2015, Brain : a journal of neurology.

[9]  Faramarz Faghihi,et al.  A computational model of pattern separation efficiency in the dentate gyrus with implications in schizophrenia , 2015, Front. Syst. Neurosci..

[10]  B. Liberg,et al.  The Functional Anatomy of Psychomotor Disturbances in Major Depressive Disorder , 2015, Front. Psychiatry.

[11]  David T. Jones,et al.  Working memory and language network dysfunctions in logopenic aphasia: a task-free fMRI comparison with Alzheimer's dementia , 2015, Neurobiology of Aging.

[12]  Delong Zhang,et al.  Widespread Increase of Functional Connectivity in Parkinson’s Disease with Tremor: A Resting-State fMRI Study , 2015, Front. Aging Neurosci..

[13]  Igor Zwir,et al.  Uncovering the hidden risk architecture of the schizophrenias: confirmation in three independent genome-wide association studies. , 2015, The American journal of psychiatry.

[14]  C. Myers,et al.  Testing the role of reward and punishment sensitivity in avoidance behavior: a computational modeling approach , 2015, Behavioural Brain Research.

[15]  R. Moratalla,et al.  Activation of DREAM (Downstream Regulatory Element Antagonistic Modulator), a Calcium-Binding Protein, Reduces L-DOPA-Induced Dyskinesias in Mice , 2015, Biological Psychiatry.

[16]  C. Myers,et al.  Acquired equivalence in U.S. veterans with symptoms of posttraumatic stress: reexperiencing symptoms are associated with greater generalization. , 2014, Journal of traumatic stress.

[17]  E. Rolls,et al.  Altered functional connectivity links in neuroleptic-naïve and neuroleptic-treated patients with schizophrenia, and their relation to symptoms including volition , 2014, NeuroImage: Clinical.

[18]  P. Brown,et al.  The nature of tremor circuits in parkinsonian and essential tremor , 2014, Brain : a journal of neurology.

[19]  Traian Popa,et al.  Cerebellum in Levodopa-Induced Dyskinesias: The Unusual Suspect in the Motor Network , 2014, Front. Neurol..

[20]  Terrence C. Stewart,et al.  A Unifying Mechanistic Model of Selective Attention in Spiking Neurons , 2014, PLoS Comput. Biol..

[21]  J. Ford,et al.  Studying Hallucinations Within the NIMH RDoC Framework , 2014, Schizophrenia bulletin.

[22]  R. Moratalla,et al.  L-DOPA Treatment Selectively Restores Spine Density in Dopamine Receptor D2–Expressing Projection Neurons in Dyskinetic Mice , 2014, Biological Psychiatry.

[23]  F. Turkheimer,et al.  Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson's disease patients. , 2014, The Journal of clinical investigation.

[24]  D. Pizzagalli,et al.  Dimensions in major depressive disorder and their relevance for treatment outcome. , 2014, Journal of affective disorders.

[25]  V. Srinivasa Chakravarthy,et al.  A computational model of altered gait patterns in parkinson's disease patients negotiating narrow doorways , 2014, Front. Comput. Neurosci..

[26]  Michael J Frank,et al.  Freezing of gait in Parkinson's disease is associated with functional decoupling between the cognitive control network and the basal ganglia. , 2013, Brain : a journal of neurology.

[27]  Chris Eliasmith,et al.  Modeling brain function: current developments and future prospects. , 2013, JAMA neurology.

[28]  Ateka A. Contractor,et al.  PTSD's underlying symptom dimensions and relations with behavioral inhibition and activation. , 2013, Journal of anxiety disorders.

[29]  C. Myers,et al.  Learning to Obtain Reward, but Not Avoid Punishment, Is Affected by Presence of PTSD Symptoms in Male Veterans: Empirical Data and Computational Model , 2013, PloS one.

[30]  D. Nutt,et al.  Anhedonia revisited: Is there a role for dopamine-targeting drugs for depression? , 2013, Journal of psychopharmacology.

[31]  Cameron S. Carter,et al.  Impaired Prefrontal-Basal Ganglia Functional Connectivity and Substantia Nigra Hyperactivity in Schizophrenia , 2013, Biological Psychiatry.

[32]  Ahmed A. Moustafa,et al.  The effects of clinical motor variables and medication dosage on working memory in Parkinson’s disease , 2013, Brain and Cognition.

[33]  Damiaan Denys,et al.  Relation Between Structural and Functional Connectivity in Major Depressive Disorder , 2013, Biological Psychiatry.

[34]  P. Dayan,et al.  Mapping anhedonia onto reinforcement learning: a behavioural meta-analysis , 2013, Biology of Mood & Anxiety Disorders.

[35]  M. Stamelou,et al.  Dopamine agonists and delusional jealousy in Parkinson's disease: A cross‐sectional prevalence study , 2013, Movement disorders : official journal of the Movement Disorder Society.

[36]  Peter J. Siekmeier,et al.  Development of Antipsychotic Medications with Novel Mechanisms of Action Based on Computational Modeling of Hippocampal Neuropathology , 2013, PloS one.

[37]  M. Hallett,et al.  The cerebellum in Parkinson’s disease , 2013, Brain : a journal of neurology.

[38]  C. Myers,et al.  A model of amygdala–hippocampal–prefrontal interaction in fear conditioning and extinction in animals , 2013, Brain and Cognition.

[39]  Trevor Bekolay,et al.  A Large-Scale Model of the Functioning Brain , 2012, Science.

[40]  P. Petersson,et al.  Levodopa-Induced Dyskinesia Is Strongly Associated with Resonant Cortical Oscillations , 2012, The Journal of Neuroscience.

[41]  E. Heremans,et al.  Explaining freezing of gait in Parkinson's disease: Motor and cognitive determinants , 2012, Movement disorders : official journal of the Movement Disorder Society.

[42]  S. Pullman,et al.  Tremor: Clinical Phenomenology and Assessment Techniques , 2012, Tremor and other hyperkinetic movements.

[43]  Songthip Ounpraseuth,et al.  Micrographia and related deficits in Parkinson's disease: a cross-sectional study , 2012, BMJ Open.

[44]  L. Rubchinsky,et al.  On the Origin of Tremor in Parkinson’s Disease , 2012, PloS one.

[45]  T Warbrick,et al.  Hippocampal subfields predict positive symptoms in schizophrenia: First evidence from brain morphometry , 2012, Translational Psychiatry.

[46]  Jeremy R. Reynolds,et al.  Anorexia Nervosa and Obesity are Associated with Opposite Brain Reward Response , 2012, Neuropsychopharmacology.

[47]  Lie-Hang Shen,et al.  Recent Advances in Imaging of Dopaminergic Neurons for Evaluation of Neuropsychiatric Disorders , 2012, Journal of biomedicine & biotechnology.

[48]  M. Hallett,et al.  Cerebral causes and consequences of parkinsonian resting tremor: a tale of two circuits? , 2012, Brain : a journal of neurology.

[49]  Antonio Cerasa,et al.  Prefrontal alterations in Parkinson's disease with levodopa‐induced dyskinesia during fMRI motor task , 2012, Movement disorders : official journal of the Movement Disorder Society.

[50]  Wolfgang M. Pauli,et al.  Expectancy, Ambiguity, and Behavioral Flexibility: Separable and Complementary Roles of the Orbital Frontal Cortex and Amygdala in Processing Reward Expectancies , 2012, Journal of Cognitive Neuroscience.

[51]  Peter A LeWitt,et al.  Norepinephrine: the next therapeutics frontier for Parkinson's disease , 2012, Translational Neurodegeneration.

[52]  J. Devin McAuley,et al.  Behaviorally inhibited temperament is associated with severity of post-traumatic stress disorder symptoms and faster eyeblink conditioning in veterans , 2012, Stress.

[53]  R. Albin,et al.  Advances in Therapeutic Options for Gait and Balance in Parkinson's Disease. , 2011, US neurology.

[54]  D. Bowers,et al.  Apathy and Depression: Separate Factors in Parkinson's Disease , 2011, Journal of the International Neuropsychological Society.

[55]  M. Hallett,et al.  Freezing of gait: moving forward on a mysterious clinical phenomenon , 2011, The Lancet Neurology.

[56]  P. McGuire,et al.  Altered prefrontal and hippocampal function during verbal encoding and recognition in people with prodromal symptoms of psychosis. , 2011, Schizophrenia bulletin.

[57]  S. Moritz,et al.  What happened to the voices? A fine-grained analysis of how hallucinations and delusions change under psychiatric treatment , 2011, Psychiatry Research.

[58]  Catherine E. Myers,et al.  General functioning predicts reward and punishment learning in schizophrenia , 2011, Schizophrenia Research.

[59]  M. Ghilardi,et al.  Apathy, but Not Depression, Reflects Inefficient Cognitive Strategies in Parkinson's Disease , 2011, PloS one.

[60]  W. Oyen,et al.  Pallidal dysfunction drives a cerebellothalamic circuit into Parkinson tremor , 2011, Annals of neurology.

[61]  L. Descarries,et al.  Maladaptive plasticity of serotonin axon terminals in levodopa‐induced dyskinesia , 2010, Annals of neurology.

[62]  Xiao-Jing Wang,et al.  Toward a neurobiology of delusions , 2010, Progress in Neurobiology.

[63]  A. Aleman,et al.  Regional brain volume in depression and anxiety disorders. , 2010, Archives of general psychiatry.

[64]  S. Bálint,et al.  Executive function in deficit schizophrenia: What do the dimensions of the Wisconsin Card Sorting Test tell us? , 2010, Schizophrenia Research.

[65]  Y. Smith,et al.  Striatal Spine Plasticity in Parkinson's Disease , 2010, Front. Neuroanat..

[66]  S. Lewis,et al.  A novel paradigm for modelling freezing of gait in Parkinson’s disease , 2010, Journal of Clinical Neuroscience.

[67]  P. McKenna,et al.  False memory in schizophrenia patients with and without delusions , 2010, Psychiatry Research.

[68]  J. Lisman,et al.  A Thalamo-Hippocampal-Ventral Tegmental Area Loop May Produce the Positive Feedback that Underlies the Psychotic Break in Schizophrenia , 2010, Biological Psychiatry.

[69]  S. Rombouts,et al.  Frontiers in Systems Neuroscience Systems Neuroscience , 2022 .

[70]  P. Liddle,et al.  Formal thought disorder in non-clinical individuals with auditory verbal hallucinations , 2010, Schizophrenia Research.

[71]  U. Bonuccelli,et al.  Differences in nigro‐striatal impairment in clinical variants of early Parkinson’s disease: evidence from a FP‐CIT SPECT study , 2010, European journal of neurology.

[72]  H. Tachibana,et al.  Apathy and Depression in Parkinson Disease , 2010, Journal of geriatric psychiatry and neurology.

[73]  A. P. Moore.  Classification of movement disorders. , 2010, Neuroimaging clinics of North America.

[74]  Simon Hong,et al.  Oculopalatal tremor explained by a model of inferior olivary hypertrophy and cerebellar plasticity , 2010, Brain : a journal of neurology.

[75]  Tatiana Witjas,et al.  Comparative analysis of gait and speech in Parkinson's disease: hypokinetic or dysrhythmic disorders? , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[76]  R. Moratalla,et al.  Genetic Inactivation of Dopamine D1 but Not D2 Receptors Inhibits L-DOPA–Induced Dyskinesia and Histone Activation , 2009, Biological Psychiatry.

[77]  M. Mandelkern,et al.  The neural correlates of naming and fluency deficits in Alzheimer's disease: an FDG‐PET study , 2009, International journal of geriatric psychiatry.

[78]  Hagai Bergman,et al.  Akineto-rigid vs. tremor syndromes in Parkinsonism , 2009, Current opinion in neurology.

[79]  J. Obeso,et al.  Homocysteine and cognitive impairment in Parkinson's disease: A biochemical, neuroimaging, and genetic study , 2009, Movement disorders : official journal of the Movement Disorder Society.

[80]  Catherine E. Myers,et al.  Associative Learning, Acquired Equivalence, and Flexible Generalization of Knowledge in Mild Alzheimer Disease , 2009, Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology.

[81]  Ludovico Minati,et al.  Reviews: Current Concepts in Alzheimer's Disease: A Multidisciplinary Review , 2009, American journal of Alzheimer's disease and other dementias.

[82]  Szabolcs Kéri,et al.  Interactive memory systems and category learning in schizophrenia , 2008, Neuroscience & Biobehavioral Reviews.

[83]  T. Gómez-Isla,et al.  Homocysteine and Cognitive Impairment , 2008, Dementia and Geriatric Cognitive Disorders.

[84]  M. Brin,et al.  Consensus Statement of the Movement Disorder Society on Tremor , 2008, Movement disorders : official journal of the Movement Disorder Society.

[85]  Sidney H. Kennedy,et al.  Core symptoms of major depressive disorder: relevance to diagnosis and treatment , 2008, Dialogues in clinical neuroscience.

[86]  Godfrey D Pearlson,et al.  Neuropsychological impairment in deficit vs. non-deficit schizophrenia. , 2008, Journal of psychiatric research.

[87]  M. Furey,et al.  Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression , 2008, Brain Structure and Function.

[88]  Dan J Stein.  Depression, Anhedonia, and Psychomotor Symptoms: The Role of Dopaminergic Neurocircuitry , 2008, CNS Spectrums.

[89]  Catherine E. Myers,et al.  Associative learning in deficit and nondeficit schizophrenia , 2008, Neuroreport.

[90]  Michael J. Frank,et al.  Hold Your Horses: Impulsivity, Deep Brain Stimulation, and Medication in Parkinsonism , 2007, Science.

[91]  R. Lanius,et al.  Neural correlates of reexperiencing, avoidance, and dissociation in PTSD: symptom dimensions and emotion dysregulation in responses to script-driven trauma imagery. , 2007, Journal of traumatic stress.

[92]  Y. Lecrubier,et al.  Physician observations and perceptions of positive and negative symptoms of schizophrenia: A multinational, cross-sectional survey , 2007, European Psychiatry.

[93]  Klaus P. Ebmeier,et al.  Blunted response to feedback information in depressive illness. , 2007, Brain : a journal of neurology.

[94]  Canan Ozsancak,et al.  Oral festination in Parkinson's disease: Biomechanical analysis and correlation with festination and freezing of gait , 2007, Movement disorders : official journal of the Movement Disorder Society.

[95]  C. Goetz,et al.  Levodopa‐induced dyskinesias , 2007, Movement disorders : official journal of the Movement Disorder Society.

[96]  D. Nutt,et al.  The other face of depression, reduced positive affect: the role of catecholamines in causation and cure , 2007, Journal of psychopharmacology.

[97]  H. Möller,et al.  Long-acting risperidone improves negative symptoms in stable psychotic patients , 2007, European Psychiatry.

[98]  U. Dillmann,et al.  Striatal FP-CIT uptake differs in the subtypes of early Parkinson’s disease , 2007, Journal of Neural Transmission.

[99]  S. Stahl,et al.  Pharmacological treatment of negative symptoms of schizophrenia: therapeutic opportunity or Cul‐de‐sac? , 2007, Acta psychiatrica Scandinavica.

[100]  Marc W Howard,et al.  Modeling of context-dependent retrieval in hippocampal region CA1: Implications for cognitive function in schizophrenia , 2007, Schizophrenia Research.

[101]  J. Soghomonian.  L‐DOPA‐induced dyskinesia in adult rats with a unilateral 6‐OHDA lesion of dopamine neurons is paralleled by increased c‐fos gene expression in the subthalamic nucleus , 2006, The European journal of neuroscience.

[102]  C. K. Gurung,et al.  An open, randomized, comparative study of efficacy and safety of risperidone and haloperidol in schizophrenia. , 2006, Kathmandu University medical journal.

[103]  T. Crow,et al.  Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. , 2005, The American journal of psychiatry.

[104]  Nora Turjanski,et al.  Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. , 2005, Brain : a journal of neurology.

[105]  T. Chase,et al.  Continuous dopaminergic stimulation reduces risk of motor complications in parkinsonian primates , 2005, Experimental Neurology.

[106]  A. Goberman,et al.  Correlation between acoustic speech characteristics and non-speech motor performance in Parkinson Disease. , 2005, Medical science monitor : international medical journal of experimental and clinical research.

[107]  B. Ravnkilde,et al.  Hippocampal volume and depression: a meta-analysis of MRI studies. , 2004, The American journal of psychiatry.

[108]  M. E. Ballard,et al.  Chronic low dose risperidone and clozapine alleviate positive but not negative symptoms in the rat neonatal ventral hippocampal lesion model of schizophrenia , 2004, Psychopharmacology.

[109]  A. David.  The cognitive neuropsychiatry of auditory verbal hallucinations: an overview. , 2004, Cognitive neuropsychiatry.

[110]  Anissa Abi-Dargham,et al.  Probing cortical dopamine function in schizophrenia: what can D1 receptors tell us? , 2003, World psychiatry : official journal of the World Psychiatric Association.

[111]  B. Mensour,et al.  Neural circuitry underlying voluntary suppression of sadness , 2003, Biological Psychiatry.

[112]  L. Bäckman,et al.  Cognitive deficits in preclinical Alzheimer's disease , 2003, Acta neurologica Scandinavica. Supplementum.

[113]  M. Gluck,et al.  Dissociating Hippocampal versus Basal Ganglia Contributions to Learning and Transfer , 2003, Journal of Cognitive Neuroscience.

[114]  M. Raichle,et al.  Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism , 2002, European Neuropsychopharmacology.

[115]  R. O’Reilly,et al.  Opinion TRENDS in Cognitive Sciences Vol.6 No.12 December 2002 , 2022 .

[116]  M. Shenton,et al.  Smaller hippocampal volume predicts pathologic vulnerability to psychological trauma , 2002, Nature Neuroscience.

[117]  R. Kahn,et al.  Brain volume changes in first-episode schizophrenia: a 1-year follow-up study. , 2002, Archives of general psychiatry.

[118]  J. Becker,et al.  [The semantic memory deficit in Alzheimer's disease]. , 2002, Revista de neurologia.

[119]  R. V. Van Heertum,et al.  Prefrontal Dopamine D1 Receptors and Working Memory in Schizophrenia , 2002, The Journal of Neuroscience.

[120]  R. Barker,et al.  The heterogeneity of idiopathic Parkinson's disease , 2002, Journal of Neurology.

[121]  M. Lambert,et al.  Neuropsychological correlates of schizophrenic syndromes in patients treated with atypical neuroleptics , 2001, European Psychiatry.

[122]  J. Jankovic,et al.  Freezing of gait in PD: Prospective assessment in the DATATOP cohort , 2001 .

[123]  C. Burgess,et al.  Age vs Alzheimer's: A computational model of changes in representation , 2001, Brain and Cognition.

[124]  J. Dostrovsky,et al.  High-frequency Synchronization of Neuronal Activity in the Subthalamic Nucleus of Parkinsonian Patients with Limb Tremor , 2000, The Journal of Neuroscience.

[125]  G. Deuschl,et al.  The pathophysiology of parkinsonian tremor: a review , 2000, Journal of Neurology.

[126]  G. Deuschl,et al.  Multiple oscillators are causing parkinsonian and essential tremor , 2000, Movement disorders : official journal of the Movement Disorder Society.

[127]  A. Fink-Jensen.  Novel pharmacological approaches to the treatment of schizophrenia , 2000, Danish medical bulletin.

[128]  N. Alpert,et al.  Functional imaging of memory retrieval in deficit vs nondeficit schizophrenia. , 1999, Archives of general psychiatry.

[129]  W. Drevets.  Prefrontal Cortical‐Amygdalar Metabolism in Major Depression , 1999, Annals of the New York Academy of Sciences.

[130]  L. Parsons,et al.  Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. , 1999, The American journal of psychiatry.

[131]  R. Rosenheck,et al.  A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. , 1997, The New England journal of medicine.

[132]  M. Hasselmo,et al.  A computational model of the progression of Alzheimer's disease. , 1997, M.D. computing : computers in medical practice.

[133]  H. Miyaoka,et al.  False Memory in Schizophrenia , 1997, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[134]  M. Iyo,et al.  Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET , 1997, Nature.

[135]  R. O’Reilly,et al.  A computational approach to prefrontal cortex, cognitive control and schizophrenia: recent developments and current challenges. , 1996, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[136]  H. Möller,et al.  [123I]IBZM SPECT for imaging of striatal D2 dopamine receptors in 56 schizophrenic patients taking various neuroleptics. , 1996, The American journal of psychiatry.

[137]  A. Wagstaff,et al.  Clozapine: A Review of its Pharmacological Properties and Therapeutic Use in Patients with Schizophrenia Who Are Unresponsive to or Intolerant of Classical Antipsychotic Agents , 1995 .

[138]  James L. McClelland,et al.  Why there are complementary learning systems in the hippocampus and neocortex: insights from the successes and failures of connectionist models of learning and memory. , 1995, Psychological review.

[139]  L. Squire,et al.  Retrograde amnesia and memory consolidation: a neurobiological perspective , 1995, Current Opinion in Neurobiology.

[140]  A. Hofman,et al.  Apolipoprotein E genotype and association between smoking and early onset Alzheimer's disease , 1995, BMJ.

[141]  Eric Y.H. Chen,et al.  A Neural Network Model of Cortical Information Processing in Schizophrenia II - Role of Hippocampal-Cortical Interaction: A Review and a Model , 1995, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[142]  J A Reggia,et al.  A Neural Model of Memory Impairment in Di(cid:11)use Cerebral Atrophy , 2004 .

[143]  A. Smith,et al.  Negative symptoms in schizophrenia: assessment of the effect of risperidone. , 1994 .

[144]  S. Rapcsak,et al.  Implicit and Explicit Memory Following Anterior Communicating Artery Aneurysm Rupture , 1993, Brain and Cognition.

[145]  C. Eisdorfer,et al.  A comparison of familial and sporadic Alzheimer's disease , 1993, Neurology.

[146]  N. Andreasen,et al.  Clozapine's effect on negative symptoms in treatment-refractory schizophrenics , 1993, Schizophrenia Research.

[147]  J. Brodie,et al.  Negative symptoms and hypofrontality in chronic schizophrenia. , 1992, Archives of general psychiatry.

[148]  R. Heel,et al.  Clozapine. A review of its pharmacological properties, and therapeutic use in schizophrenia. , 1990, Drugs.

[149]  J. Penney,et al.  The functional anatomy of basal ganglia disorders , 1989, Trends in Neurosciences.

[150]  G Honigfeld,et al.  Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. , 1988, Archives of general psychiatry.

[151]  S. Kish,et al.  Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. , 1988, The New England journal of medicine.

[152]  N. Foster,et al.  Cerebral mapping of apraxia in Alzheimer's disease by positron emission tomography , 1986, Annals of neurology.

[153]  David M. Ludlum.  An Uneven Pattern , 1984 .

[154]  G. K. Wilcock,et al.  Plaques, tangles and dementia A quantitative study , 1982, Journal of the Neurological Sciences.

[155]  J. Cowan,et al.  A mathematical theory of visual hallucination patterns , 1979, Biological Cybernetics.

[156]  B. Maher,et al.  Delusional thinking and perceptual disorder. , 1974, Journal of individual psychology.

[157]  H. Engeland,et al.  Brain Volume Changes in First-Episode Schizophrenia , 2015 .

[158]  Á. Pascual-Leone,et al.  Transcranial Magnetic Stimulation , 2014, Neuromethods.

[159]  P. Petersson,et al.  Mechanisms underlying cortical resonant states: implications for levodopa-induced dyskinesia , 2013, Reviews in the neurosciences.

[160]  P. Jenner,et al.  Striatal plasticity in Parkinson's disease and L-dopa induced dyskinesia. , 2012, Parkinsonism & related disorders.

[161]  S. Skodda,et al.  Gender-related patterns of dysprosody in Parkinson disease and correlation between speech variables and motor symptoms. , 2011, Journal of voice : official journal of the Voice Foundation.

[162]  Wiesje M van der Flier,et al.  Early-versus late-onset Alzheimer's disease: more than age alone. , 2010, Journal of Alzheimer's disease : JAD.

[163]  Ainhoa Berciano-Alcaraz,et al.  A computational approach of , 2010 .

[164]  J. Matías‐Guiu,et al.  [Apathy in Parkinson's disease]. , 2010, Neurologia.

[165]  D. Nutt.  Relationship of neurotransmitters to the symptoms of major depressive disorder. , 2008, The Journal of clinical psychiatry.

[166]  Oiwi Parker Jones,et al.  A Computational Approach , 2008 .

[167]  P. Remy,et al.  Executive function deficits in early Alzheimer's disease and their relations with episodic memory. , 2006, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[168]  Tomas Palenicek,et al.  Mechanism of Action of Atypical Antipsychotic Drugs and the Neurobiology of Schizophrenia , 2006, CNS drugs.

[169]  D. Hansell,et al.  Recent Advances in Imaging , 2006 .

[170]  John H Krystal,et al.  Transcranial magnetic stimulation of left temporoparietal cortex and medication-resistant auditory hallucinations. , 2003, Archives of general psychiatry.

[171]  J. Davidson,et al.  Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms , 2002, Depression and anxiety.

[172]  H. Meltzer.  MECHANISM OF ACTION OF ATYPICAL ANTIPSYCHOTIC DRUGS , 2002 .

[173]  A Carlsson,et al.  Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. , 2001, Annual review of pharmacology and toxicology.

[174]  B. Mowry,et al.  Molecular genetics of schizophrenia. , 2001, Clinical and experimental pharmacology & physiology.

[175]  B. Mowry,et al.  Proceedings of the Australian Neuroscience Society Symposium: Schizophrenia MOLECULAR GENETICS OF SCHIZOPHRENIA , 2001 .

[176]  R. Murray,et al.  Meta-analysis of regional brain volumes in schizophrenia. , 2000, The American journal of psychiatry.

[177]  S. Risch.  Pathophysiology of Schizophrenia and the Role of Newer Antipsychotics , 1996, Pharmacotherapy.

[178]  M. Farah,et al.  A computational model of naming in Alzheimer's disease: Unitary or multiple impairments? , 1994 .

[179]  N. Schooler.  Negative symptoms in schizophrenia: assessment of the effect of risperidone. , 1994, The Journal of clinical psychiatry.

[180]  N. Andreasen,et al.  Clozapine's effect on negative symptoms in treatment-refractory schizophrenics☆ , 1994 .

[181]  W T Carpenter,et al.  Structural abnormalities in deficit and nondeficit schizophrenia. , 1993, The American journal of psychiatry.

[182]  B. Weinshenker,et al.  A COMPARISON OF FAMILIAL AND SPORADIC MS , 1986 .